These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11948282

  • 1. Valsartan in chronic heart failure.
    Haddy FJ.
    N Engl J Med; 2002 Apr 11; 346(15):1173-4. PubMed ID: 11948282
    [No Abstract] [Full Text] [Related]

  • 2. Valsartan in chronic heart failure.
    Campbell DJ.
    N Engl J Med; 2002 Apr 11; 346(15):1173-4. PubMed ID: 11951863
    [No Abstract] [Full Text] [Related]

  • 3. Valsartan in chronic heart failure.
    Forfar JC, Munir S.
    N Engl J Med; 2002 Apr 11; 346(15):1173-4. PubMed ID: 11951862
    [No Abstract] [Full Text] [Related]

  • 4. Valsartan in chronic heart failure.
    Cayley WE.
    N Engl J Med; 2002 Apr 11; 346(15):1173-4. PubMed ID: 11951861
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 11; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators.
    N Engl J Med; 2001 Dec 06; 345(23):1667-75. PubMed ID: 11759645
    [Abstract] [Full Text] [Related]

  • 7. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M.
    Heart Fail Monit; 2002 Dec 06; 2(3):85-7. PubMed ID: 12634889
    [Abstract] [Full Text] [Related]

  • 8. [Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor].
    MMW Fortschr Med; 2002 Oct 03; 144(40):49. PubMed ID: 12440300
    [No Abstract] [Full Text] [Related]

  • 9. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Tepper D.
    Congest Heart Fail; 2002 Oct 03; 8(1):57-8. PubMed ID: 11821630
    [No Abstract] [Full Text] [Related]

  • 10. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD, Friedman JY, Velazquez EJ, Gnanasakthy A, Califf RM, Schulman KA.
    Am Heart J; 2004 Jul 03; 148(1):122-8. PubMed ID: 15215801
    [Abstract] [Full Text] [Related]

  • 11. BP drug approved for heart failure.
    Health News; 2002 Oct 03; 8(10):9. PubMed ID: 12416491
    [No Abstract] [Full Text] [Related]

  • 12. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.
    Krum H, Carson P, Farsang C, Maggioni AP, Glazer RD, Aknay N, Chiang YT, Cohn JN.
    Eur J Heart Fail; 2004 Dec 03; 6(7):937-45. PubMed ID: 15556056
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW, Berent R, Eber B.
    Circulation; 2001 Oct 09; 104(15):E82. PubMed ID: 11591633
    [No Abstract] [Full Text] [Related]

  • 14. Effect of Valsartan on hospitalization: results from Val-HeFT.
    Carson P, Tognoni G, Cohn JN.
    J Card Fail; 2003 Jun 09; 9(3):164-71. PubMed ID: 12815565
    [Abstract] [Full Text] [Related]

  • 15. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep 05; 144(35-36):57. PubMed ID: 12380364
    [No Abstract] [Full Text] [Related]

  • 16. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
    MMW Fortschr Med; 2003 Dec 04; 145(49):18-9. PubMed ID: 14963986
    [No Abstract] [Full Text] [Related]

  • 17. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Hollenberg NK.
    Curr Hypertens Rep; 2002 Dec 20; 4(6):411; discussion 412. PubMed ID: 12462208
    [No Abstract] [Full Text] [Related]

  • 19. Lessons learned from the valsartan- heart failure trial (Val-HeFT): angiotensin receptor blockers in heart failure.
    Cohn JN.
    Am J Cardiol; 2002 Nov 01; 90(9):992-3. PubMed ID: 12398968
    [No Abstract] [Full Text] [Related]

  • 20. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.